We have just completed the latest data update to BiomarkerBase, which includes the following new information:
1,161 Biomarkers (unique Target/Disease combinations)
As we mentioned in our last product update post, this is the second of a few product updates in October. That brings the grand total so far in October to:
- 2,260 new clinically validated biomarkers
- 119 new Targets
- 50 new Diseases
- 52 new Drugs
- 197 new Clinical Trials
Over the next two weeks we expect to add another 10k trials to our coverage and several hundred biomarkers, biomarker targets, diseases and drugs.
We’re very excited so stay tuned.